Patel Sandip I insider trades
Patel Sandip I has filed 11 Form 4s with the SEC that we hold, for AtlasClear Holdings, Inc. (ATCH) (CFO and General Counsel, Director), Akari Therapeutics Plc (AKTX) (Director), MTRY (Director, 10% owner) and PKBO (Director), among 5 companies in all. Across all of them we count 2 purchases worth $20.7K and 1 sale worth $5.7K reported on Form 4. In the last 12 months: 2 purchases ($20.7K) and 0 sales ($0). The largest single trade was a purchase of 50,000 shares of AtlasClear Holdings, Inc. worth $10.9K, dated 2026-09-24. The first filing on our record is dated 2023-03-13 and the latest 2026-10-02.
AtlasClear Holdings, Inc. (ATCH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-09-24 | P, purchase reported on Form 4 | 50,000 | $10.9K | 2026-09-28 |
| 2026-09-25 | P, purchase reported on Form 4 | 50,000 | $9.9K | 2026-09-28 |
Akari Therapeutics Plc (AKTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MTRY
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-03-09 | S, sale reported on Form 4 | 570,000 | $5.7K | 2023-03-13 |
PKBO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
QFTA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1843601) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms